Interestingly, recent studies have demonstrated that plasma GFAP is a better predictor of AD pathology than CSF GFAP; one reason that this could be the case is that plasma GFAP is indicative of astrocytosis severe enough to cause BBB damage/leakage.156, 162. This evidence concerns the gene GFAP and Alzheimer disease.